Rocket Science Health Featured in BIOTECanada’s Insights magazine
Author: Rocket Science Health
BTC Insights Magazine Spring 2026
We're excited to announce that Rocket Science Health has been featured in the latest issue of BIOTECanada’s Insights magazine!
In drug development, a breakthrough molecule means nothing if it can't reach its target. Rocket Science Health is tackling one of medicine's most persistent challenges: delivering therapeutics to the brain. The blood-brain barrier blocks roughly 95% of drugs from reaching the central nervous system, limiting treatment options for millions of people living with neurological disorders.
Our intranasal delivery platform uses laminar fluid ejection technology – principles borrowed from the oil pipeline engineering experience of our founder – to bypass the blood-brain barrier entirely and deliver therapeutics directly to the brain through the olfactory cleft.
Our Insights feature covers our technology, the peer-reviewed research behind it, and its potential applications for drug development, spanning mental health and neurodegenerative diseases to mRNA vaccines.
Read the full article below or view it on page 72 at:
